↓ Skip to main content

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis

Overview of attention for article published in this source, October 2012
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
145 Dimensions

Readers on

mendeley
127 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
Published by
John Wiley & Sons, Ltd, October 2012
DOI 10.1002/14651858.cd000544.pub3
Pubmed ID
Authors

Feagan, Brian G, MacDonald, John K

Abstract

Oral 5-aminosalicylic (5-ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Previously, it was found that 5-ASA drugs were more effective than placebo but had a statistically significant therapeutic inferiority relative to SASP. This updated review includes more recent studies and evaluates the effectiveness, dose-responsiveness, and safety of 5-ASA preparations used for maintenance of remission in quiescent ulcerative colitis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
United States 2 2%
Germany 2 2%
Czechia 1 <1%
Unknown 120 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 17%
Student > Master 14 11%
Other 12 9%
Student > Bachelor 12 9%
Student > Ph. D. Student 11 9%
Other 32 25%
Unknown 24 19%
Readers by discipline Count As %
Medicine and Dentistry 64 50%
Agricultural and Biological Sciences 10 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Nursing and Health Professions 5 4%
Psychology 4 3%
Other 11 9%
Unknown 26 20%